![]() | ECOG-E1910 study: clinical benefit of early blinatumomab incorporation in ALL Süre: 1:03 | Boyut: 2.4 MB |
![]() | Final results of ALLG ALL08: blinatumomab with reduced intensity chemo in older adults with B-ALL Süre: 1:22 | Boyut: 3.13 MB |
![]() | Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia- R. Raja Süre: 12:47 | Boyut: 29.26 MB |
![]() | A trial investigating the addition of blinatumomab to consolidation chemotherapy in Ph- ALL Süre: 3:35 | Boyut: 8.2 MB |
![]() | ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib Effective in Ph+ ALL & CML Süre: 1:04 | Boyut: 2.44 MB |
![]() | A phase II study of blinatumomab for the treatment of MRD-positive B-cell acute lymphoblastic le... Süre: 5:52 | Boyut: 13.43 MB |